Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wallis

Showing results (241-250 of 273) with videos related to

Pageof 28
Sort By:
The British Journal of Radiology|January 6, 2023
Lessons learned from independent external validation of an AI tool to detect breast cancer using a representative UK data setDominic Cushnan, Kenneth C Young, Dominic Ward, et al.
Annals of Plastic Surgery|September 25, 2010
Making medical gloves safeRichard F Edlich, George T Rodeheaver, John G Thacker, et al.
Journal of the National Cancer Institute|March 6, 2019
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 RadiologistsAlejandro Rodriguez-Ruiz, Kristina Lång, Albert Gubern-Merida, et al.
BMJ (Clinical Research Ed.)|February 1, 2024
Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in EnglandKaroline Freeman, David Jenkinson, Karen Clements, et al.
Molecular Cancer Therapeutics|June 21, 2012
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor modelsTomoko Smyth, Thomas Van Looy, Jayne E Curry, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2018
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane ProjectAlastair M Thompson, Karen Clements, Shan Cheung, et al.
Photoacoustics|September 7, 2022
An optoacoustic imaging feature set to characterise blood vessels surrounding benign and malignant breast lesionsO Abeyakoon, R Woitek, M G Wallis, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
Molecular Cancer Therapeutics|October 29, 2014
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma modelsTomoko Smyth, Kim H T Paraiso, Keisha Hearn, et al.
BMJ (Clinical Research Ed.)|August 28, 2004
Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort studyEmily Banks, Gillian Reeves, Valerie Beral, et al.
Pageof 28

Showing results (241-250 of 273) with videos related to

Sort By:
Pageof 28
The British Journal of Radiology|January 6, 2023
Lessons learned from independent external validation of an AI tool to detect breast cancer using a representative UK data setDominic Cushnan, Kenneth C Young, Dominic Ward, et al.
Annals of Plastic Surgery|September 25, 2010
Making medical gloves safeRichard F Edlich, George T Rodeheaver, John G Thacker, et al.
Journal of the National Cancer Institute|March 6, 2019
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 RadiologistsAlejandro Rodriguez-Ruiz, Kristina Lång, Albert Gubern-Merida, et al.
BMJ (Clinical Research Ed.)|February 1, 2024
Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in EnglandKaroline Freeman, David Jenkinson, Karen Clements, et al.
Molecular Cancer Therapeutics|June 21, 2012
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor modelsTomoko Smyth, Thomas Van Looy, Jayne E Curry, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2018
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane ProjectAlastair M Thompson, Karen Clements, Shan Cheung, et al.
Photoacoustics|September 7, 2022
An optoacoustic imaging feature set to characterise blood vessels surrounding benign and malignant breast lesionsO Abeyakoon, R Woitek, M G Wallis, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
Molecular Cancer Therapeutics|October 29, 2014
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma modelsTomoko Smyth, Kim H T Paraiso, Keisha Hearn, et al.
BMJ (Clinical Research Ed.)|August 28, 2004
Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort studyEmily Banks, Gillian Reeves, Valerie Beral, et al.
Pageof 28